The fact
Developed by Novo Nordisk, the treatment targets a rapidly growing condition.
This approval could expand access to care for millions of patients.
Click the link to read an article on the topic:
Discover
Developed by Novo Nordisk, the treatment targets a rapidly growing condition.
This approval could expand access to care for millions of patients.